Browse the full directors' dealings record of Enfusion, Inc., a publicly traded company based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Business Services sector, Enfusion, Inc. has logged 22 public disclosures. The latest transaction was filed on 17 June 2022 — Attribution. Among the most active insiders: LEIBOWITZ LAWRENCE E. The full history is free.
22 of 22 declarations
Enfusion, Inc. (ticker: ENFN) is a U.S.-based company listed on the NYSE/NASDAQ in the United States, focused on technology and services for the investment management industry. Founded in 1997 and headquartered in Chicago, Illinois, Enfusion has built its business around a cloud-based software platform designed to support the full investment lifecycle, from the front office through the back office. Its customer base is primarily made up of hedge funds, asset managers, multi-asset investment firms, family offices, trading teams, operations groups, and compliance functions. The company’s core offering is an integrated platform that combines several functions that are often handled by separate systems. Enfusion provides a Portfolio Management System that can generate a real-time investment book of record, with valuation, risk, and portfolio analytics tools. It also offers an Order and Execution Management System, enabling portfolio managers, traders, analysts, and compliance teams to create, track, and control orders across multiple asset classes. In addition, the platform includes reporting, analytics, workflow, and automation capabilities designed to streamline investment operations. This front-to-back integration is one of Enfusion’s main competitive differentiators in a market that is often fragmented across multiple vendors. From a competitive standpoint, Enfusion operates in a segment supported by the secular digitization of buy-side workflows, tighter regulatory expectations, and the growing need for real-time consolidated data. Its proposition is centered on a single cloud-native platform intended to reduce operational complexity while improving visibility into positions, risk, and trade activity. The company positions itself as a provider of institutional-grade tools for globally distributed investment teams. Geographically, Enfusion operates from the United States but serves an international client base, which fits the global nature of capital markets. Public filings indicate that the company maintains investor-relations and reporting resources through its corporate website. Recent investor-relevant developments include its 2025 annual report, which highlights continued investment in technology, compliance, and the obligations associated with being a public company. Recent SEC Form 4 filings also indicate ongoing insider transaction activity, though such activity should always be interpreted carefully and in context. For French-speaking investors, ENFN offers exposure to the structural trend toward automation in asset management, through a U.S. NYSE/NASDAQ-listed business in the business services and financial-technology space.